Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ILC 2019First Drug for Fatty Liver Disease AdvancesObeticholic acid has hit a statistically significant result at 18 months in the REGENERATE trial evaluating the farnesoid X receptor agonist in patients with nonalcoholic steatohepatitis.
Liver Cancer on the Rise in Backdrop of Undiagnosed Hep CThe hepatitis C epidemic that started in the 1950s infected many patients who are now developing end-stage liver cancer, and
the number of cases is growing, researchers report.
Medscape Medical News, Apr 05, 2018
Poverty Harms Patients With Diabetes, Fatty LiverWhen patients with diabetes and nonalcoholic fatty liver disease cannot consistently afford a healthy diet, the risk for advanced
hepatic fibrosis is elevated, new research shows.
